z-logo
open-access-imgOpen Access
Projected costs associated with school-based screening to inform deployment of Dengvaxia: Vietnam as a case study
Author(s) -
Hugo C. Turner,
Bridget Wills,
Motiur Rahman,
Hoang Quoc Cuong,
Guy Thwaites,
Maciej F. Boni,
Hannah Clapham
Publication year - 2018
Publication title -
transactions of the royal society of tropical medicine and hygiene
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.725
H-Index - 105
eISSN - 1878-3503
pISSN - 0035-9203
DOI - 10.1093/trstmh/try057
Subject(s) - dengue fever , dengue vaccine , activity based costing , medicine , scale (ratio) , environmental health , geography , business , dengue virus , immunology , marketing , cartography
After new analysis, Sanofi Pasteur now recommends their dengue vaccine (Dengvaxia) should only be given to individuals previously infected with dengue and the World Health Organization's recommendations regarding its use are currently being revised. As a result, the potential costs of performing large-scale individual dengue screening and/or dengue serosurveys have become an important consideration for decision making by policymakers in dengue-endemic areas.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom